(Q43188308)

English

An active strategy to identify individuals eligible for type 2 diabetes prevention by lifestyle intervention in Dutch primary care: the APHRODITE study

scientific article published on 20 January 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

15 November 2017

An active strategy to identify individuals eligible for type 2 diabetes prevention by lifestyle intervention in Dutch primary care: the APHRODITE study (English)

1 reference

Europe PubMed Central

15 November 2017

type 2 diabetes

1 reference

based on heuristic

inferred from title

author name string

P W A Vermunt

1

1 reference

Europe PubMed Central

15 November 2017

I E J Milder

2

1 reference

Europe PubMed Central

15 November 2017

F Wielaard

3

1 reference

Europe PubMed Central

15 November 2017

J A M van Oers

4

1 reference

Europe PubMed Central

15 November 2017

G P Westert

5

1 reference

Europe PubMed Central

15 November 2017

language of work or name

0 references

publication date

20 January 2010

1 reference

Europe PubMed Central

15 November 2017

Family Practice

1 reference

Europe PubMed Central

15 November 2017

27

1 reference

Europe PubMed Central

15 November 2017

3

1 reference

Europe PubMed Central

15 November 2017

312-319

1 reference

Europe PubMed Central

15 November 2017

Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections

1 reference

https://api.crossref.org/works/10.1093%2FFAMPRA%2FCMP100

21 January 2018

Global prevalence of diabetes: estimates for the year 2000 and projections for 2030

1 reference

https://api.crossref.org/works/10.1093%2FFAMPRA%2FCMP100

21 January 2018

Preventing Type 2 diabetes and the dysmetabolic syndrome in the real world: a realistic view

1 reference

https://api.crossref.org/works/10.1093%2FFAMPRA%2FCMP100

21 January 2018

Impaired glucose tolerance and impaired fasting glycaemia: the current status on definition and intervention

1 reference

https://api.crossref.org/works/10.1093%2FFAMPRA%2FCMP100

21 January 2018

Pharmacological and lifestyle interventions to prevent or delay type 2 diabetes in people with impaired glucose tolerance: systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1093%2FFAMPRA%2FCMP100

21 January 2018

Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance

1 reference

https://api.crossref.org/works/10.1093%2FFAMPRA%2FCMP100

21 January 2018

Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin

1 reference

https://api.crossref.org/works/10.1093%2FFAMPRA%2FCMP100

21 January 2018

Impact of 3-year lifestyle intervention on postprandial glucose metabolism: the SLIM study

1 reference

https://api.crossref.org/works/10.1093%2FFAMPRA%2FCMP100

21 January 2018

Translating the Diabetes Prevention Program into the community. The DEPLOY Pilot Study

1 reference

https://api.crossref.org/works/10.1093%2FFAMPRA%2FCMP100

21 January 2018

Prevention of type 2 diabetes by lifestyle intervention in an Australian primary health care setting: Greater Green Triangle (GGT) Diabetes Prevention Project

1 reference

https://api.crossref.org/works/10.1093%2FFAMPRA%2FCMP100

21 January 2018

The diabetes risk score: a practical tool to predict type 2 diabetes risk

1 reference

https://api.crossref.org/works/10.1093%2FFAMPRA%2FCMP100

21 January 2018

Population-based stepwise screening for unrecognised Type 2 diabetes is ineffective in general practice despite reliable algorithms

1 reference

https://api.crossref.org/works/10.1093%2FFAMPRA%2FCMP100

21 January 2018

Diabetic patients detected by population-based stepwise screening already have a diabetic cardiovascular risk profile

1 reference

https://api.crossref.org/works/10.1093%2FFAMPRA%2FCMP100

21 January 2018

Do characteristics of practices and general practitioners influence the yield of diabetes screening in primary care? The ADDITION Netherlands study

1 reference

https://api.crossref.org/works/10.1093%2FFAMPRA%2FCMP100

21 January 2018

Screening for diabetes in general practice: cross sectional population study

1 reference

https://api.crossref.org/works/10.1093%2FFAMPRA%2FCMP100

21 January 2018

Study on lifestyle-intervention and impaired glucose tolerance Maastricht (SLIM): design and screening results

1 reference

https://api.crossref.org/works/10.1093%2FFAMPRA%2FCMP100

21 January 2018

A Danish diabetes risk score for targeted screening: the Inter99 study

1 reference

https://api.crossref.org/works/10.1093%2FFAMPRA%2FCMP100

21 January 2018

Low yield of population-based screening for Type 2 diabetes in the Netherlands: the ADDITION Netherlands study

1 reference

https://api.crossref.org/works/10.1093%2FFAMPRA%2FCMP100

21 January 2018

High prevalence of obesity, central obesity and abnormal glucose tolerance in the middle-aged Finnish population

1 reference

https://api.crossref.org/works/10.1093%2FFAMPRA%2FCMP100

21 January 2018

Irish diabetes detection programme in general practice

1 reference

https://api.crossref.org/works/10.1093%2FFAMPRA%2FCMP100

21 January 2018

Use of the diabetes risk score for opportunistic screening of undiagnosed diabetes and impaired glucose tolerance: the IGLOO (Impaired Glucose Tolerance and Long-Term Outcomes Observational) study.

1 reference

https://api.crossref.org/works/10.1093%2FFAMPRA%2FCMP100

21 January 2018

Identifying people at risk for undiagnosed type 2 diabetes using the GP's electronic medical record.

1 reference

https://api.crossref.org/works/10.1093%2FFAMPRA%2FCMP100

21 January 2018

Type 2 Diabetes Prevention in the "Real World": One-year results of the GOAL Implementation Trial

1 reference

https://api.crossref.org/works/10.1093%2FFAMPRA%2FCMP100

21 January 2018

The European Perspective of Type 2 Diabetes Prevention: Diabetes in Europe - Prevention Using Lifestyle, Physical Activity and Nutritional Intervention (DE-PLAN) Project

1 reference

https://api.crossref.org/works/10.1093%2FFAMPRA%2FCMP100

21 January 2018

Identifiers

10.1093/FAMPRA/CMP100

1 reference

Europe PubMed Central

15 November 2017

1 reference

Europe PubMed Central

15 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43188308&oldid=1983199869"